Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gyrus gets US nod for RF (radiofrequency) tonsil treatment:

This article was originally published in Clinica

Executive Summary

Gyrus has received US FDA 510(k) marketing clearance to use its Gyrus ENT Somnoplasty system for tonsil reduction in teenagers and adults. The minimally invasive method uses temperature controlled radiofrequency energy to reduce obstructive symptoms in enlarged tonsils. The Reading, UK-based firm already has US clearance to use the system in the treatment of obstructive sleep apnoea, chronic nasal obstruction and habitual snoring. The latest clearance provides another step in broadening the opportunity for the firm in the $1bn head and neck surgery market, says the company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066982

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel